Jove
Visualize
Contact Us

Related Experiment Videos

Inflammation and cell-cell interactions in airway hyperresponsiveness.

A R Leff1, K J Hamann, C D Wegner

  • 1Department of Medicine, University of Chicago, Illinois 60637.

The American Journal of Physiology
|April 1, 1991
PubMed
Summary

Inflammation drives airway hyperresponsiveness in asthma by recruiting granulocytes, particularly eosinophils, to the airways. These cells release proteins that increase airway smooth muscle reactivity and edema, contributing to asthma symptoms.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Models of pulmonary disease: acute and chronic allergic asthma in the monkey and acute and chronic viral pulmonitis in the mouse.

Current protocols in pharmacology·2011
Same author

Impact factor and its role in academic promotion.

The European respiratory journal·2009
Same author

Leukotriene D4 activates {beta}2-integrin adhesion in human polymorphonuclear leukocytes.

The European respiratory journal·2009
Same author

Phosphodiesterase 4 inhibition of beta2-integrin adhesion caused by leukotriene B4 and TNF-alpha in human neutrophils.

The European respiratory journal·2006
Same author

Radiofrequency ablation of airway smooth muscle for sustained treatment of asthma: preliminary investigations.

The European respiratory journal·2004
Same author

Additive blockade of beta 2-integrin adhesion of eosinophils by salmeterol and fluticasone propionate.

The European respiratory journal·2004
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Pulmonary Medicine
  • Immunology
  • Cell Biology

Background:

  • Airway hyperresponsiveness (AHR) is a hallmark of asthma, characterized by exaggerated bronchoconstriction.
  • The precise mechanisms inducing AHR are not fully understood, but inflammation is increasingly recognized as a critical factor.
  • Experimental models highlight the role of circulating granulocytes in mediating heightened bronchoconstriction during immune responses.

Purpose of the Study:

  • To investigate the role of inflammation and granulocyte migration in the development of airway hyperresponsiveness.
  • To explore the mechanisms by which granulocytes contribute to augmented airway smooth muscle contraction and edema.
  • To identify potential therapeutic targets for asthma based on inflammatory pathways.

Main Methods:

Related Experiment Videos

  • Review of experimental models and recent evidence implicating granulocytes and their adhesion molecules in airway inflammation.
  • Analysis of the molecular biology of eosinophil granule proteins and their effects on airway epithelium and smooth muscle.
  • Examination of the interaction between migrating granulocytes and airway cells (endothelial and epithelial).

    • Main Results:

    • Inflammation, particularly eosinophilic infiltration and activation, is strongly implicated in the induction and characteristic cyclic nature of AHR.
    • Upregulation of granulocyte adhesion molecules on airway endothelial and epithelial cells facilitates targeted migration.
    • Granulocyte interactions with airway cells release mediators that enhance smooth muscle responsiveness and cause edema.
    • Eosinophil granule proteins, such as major basic protein, directly stimulate epithelial secretion, increasing airway smooth muscle reactivity.

    Conclusions:

    • Inflammation is a fundamental component of airway hyperresponsiveness and asthma.
    • Eosinophils play a key role in mediating AHR through the release of cytotoxic and signaling proteins.
    • Understanding these inflammatory mechanisms opens avenues for novel asthma therapies.